GLP-1 Receptor Agonist Safety: Retinopathy, Psychiatric Signals and Perioperative Guidance
Abstract
GLP-1 receptor agonists are generally well tolerated, but concerns regarding diabetic retinopathy, optic neuropathy, psychiatric effects and aspiration risk during anaesthesia warrant clinical consideration. Current evidence supports individualised risk assessment and appropriate monitoring rather than routine treatment withdrawal.
Background
Gastrointestinal adverse events are the most common tolerability concerns. In STEP 1, 74.2% of participants receiving semaglutide reported gastrointestinal events versus 47.9% receiving placebo; most were mild to moderate [1]. Other safety concerns require interpretation in the context of emerging clinical and regulatory evidence.
Sign in to continue reading
Preview is visible for quick review. Log in or register to continue with the full articles and the rest of Docuniv.